Alistair Strachan

Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK.

Part of Boston Scientific Corp., BTG International Ltd. is a British company that engages in research and experimental development on natural sciences and engineering. The company is based in London, UK and was founded in 1991.

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom.

Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom.

CXR Biosciences Ltd. provides drug development solutions and investigative toxicology services. Its drug development solutions include bioavailability, patient response variation, drug and drug interactions, drug reactions, toxicity, reactive metabolites, customized assay development, and anticancer drug development services. The firm serves pharmaceutical, biotech, agrochemical, consumer product, and fine chemical industries. The company was founded by Clifford Roy Elcombe and Roland Charles Wolf in December 2001 and is headquartered in Dundee, the United Kingdom.

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.

Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom.

Arrayjet Ltd. develops and produces microarray printing technologies for researchers, drug development groups, and diagnostic companies. Its products include Sprint, Marathon and Super Marathon, Ultra Marathon I and II Microarrayers. The company was founded by Howard John Manning, Peter Ghazal and Douglas Roy in 2000 and is headquartered in Roslin, the United Kingdom.

Ocutec Ltd. develops medical devices. It , develops, and markets polyethylene glycol based contact lens materials for vision correction and eye-care markets. The company was founded by Neil Graham in 2001 and is headquartered in Bellshill, the United Kingdom.

SGS Vitrology Ltd. develops systems for biopharmaceutical testing. The firm also provides bio-informatics, bio-processing bio-manufacturing services, gene therapy, lab services, supplies and virology services. The company was founded in 2007 and is headquartered in Glasgow, the United Kingdom.

Trig Avionics Ltd. provides avionics products for aircraft owners and operators. The firm’s products include transponders, radios, and WAAS GPS receiver and antenna. The company was founded by Davis Andy in January 2004 and is headquartered in Edinburgh, the United Kingdom.

Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom.

Solus Scientific Solutions Ltd. provides diagnostics and microbiological testing services. Its products encompass pathogens, Allergens, and Meat Species Identification. The company was founded by Stewart Wallace and William H. Stimson in June 2009 and is headquartered in Mansfield, the United Kingdom.

Netthings Ltd. develops real time smart energy monitoring system. It products include business systems and housing systems. The firm offer immediate, real-time data through the traffic light display and detailed graphical data portal. The company was founded by Tanya Ewing and Kenneth Mccorkindale on December 28, 2006 and is headquartered in Glasgow, the United Kingdom.

Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom.

EOS Syndicate Management is an independent venture capital firm founded in 2014 by Kevin Grainger. The firm is headquartered in Scotland, United Kingdom.

3F BIO Ltd. engages in conducting biotechnological research. The company was founded by Robert James Taylor Laird, Craig Johnston and David Ritchie in and is headquartered in Glasgow, the United Kingdom.

Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014.

IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom.

MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.